Glycopyrrolate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Glycopyrrolate Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 07/30/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-578-02
- Dosage Form
- Injection
- Presentation
- Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02)
- Initial Posting
- 07/30/2026
- Revised Date